Science Explorer Back to mapMap
Discussion
Researcher · Sun Yat-sen University · China

Liejing Lu

Liejing Lu publishes mostly in Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, on topics such as RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery and Nerve injury and regeneration.

ORCID 0000-0001-6073-950X OpenAlex
World rank
#1,931,724
of 7,710,434 ranked researchers
Rank in China
#296,115
of 978,568
Works
44
Citations
1.2k
Citations per work
27.3
h-index
21
i10-index 30Top 30% in Molecular Biology
Liejing Lu

What does Liejing Lu research?

Liejing Lu's work is mostly in Biochemistry, Genetics and Molecular Biology (15%), Medicine (15%), Engineering (11%).

Everything else: 20 works · 45.6% of their workLife Sciences: 9 works · 21.1% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 15.4% of their workMolecular Biology: 7 works · 15.4% of their workNeuroscience: 3 works · 5.7% of their workCellular and Molecular Neuroscience: 3 works · 5.7% of their workPhysical Sciences: 8 works · 17.9% of their workEngineering: 5 works · 10.6% of their workBiomedical Engineering: 5 works · 10.6% of their workMaterials Science: 3 works · 7.3% of their workBiomaterials: 3 works · 7.3% of their workHealth Sciences: 7 works · 15.4% of their workMedicine: 7 works · 15.4% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 8.1% of their workSurgery: 3 works · 7.3% of their workTHEIR WORKLiejing Lu44works
Life Sciences21%Physical Sciences18%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2045.6%
    1. Biochemistry, Genetics and Molecular Biology715.4%
    2. Neuroscience35.7%
    1. Engineering510.6%
    2. Materials Science37.3%
    1. Medicine715.4%
  1. 1Molecular Biology15% of their works
  2. 2Biomedical Engineering11% of their works
  3. 3Radiology, Nuclear Medicine and Imaging8% of their works
  4. 4Surgery7% of their works
  5. 5Biomaterials7% of their works
  6. 6Cellular and Molecular Neuroscience6% of their works

Research topics

Which keywords describe Liejing Lu's research?

The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Biomedical Applications, Drug Delivery, RNA Interference, siRNA Delivery, Nanocarriers and Surface Engineering.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Nanoparticles162 topics
  2. Tumor Targeting162 topics
  3. Biomedical Applications122 topics
  4. Drug Delivery122 topics
  5. RNA Interference101 topic
  6. siRNA Delivery101 topic
  7. Nanocarriers91 topic
  8. Surface Engineering91 topic
  9. BDNF71 topic
  10. Neurotrophins71 topic
  11. Photothermal Therapy71 topic
  12. Reactive Oxygen Species71 topic
  13. Adult Stem Cells61 topic
  14. Neurogenesis61 topic
  15. Medical Imaging41 topic
  16. Mesenchymal Stem Cells41 topic
  17. Multipotent41 topic
  18. Radiomics41 topic
  19. Graphene31 topic
  20. Nanomaterials31 topic

Where does Liejing Lu work?

Liejing Lu's main affiliation in the publication record is Sun Yat-sen University, China.

How many publications and citations does Liejing Lu have?

OpenAlex counts 44 works and 1,202 citations for Liejing Lu, an h-index of 21, ranking #1,931,724 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Liejing Lu. Posts are plain text and can be reported.